Entity

Eli Lilly

U.S. pharma major behind Mounjaro and Zepbound — the biggest beneficiary of the obesity-drug boom.

As of 30 Oct 2026Last evidence 30 Oct 2026

What is happening now

  • Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

    Reported claim · first reported 28 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

  • New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer

    Reported claim · first reported 24 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

All 2 events and claims involving Eli Lilly

What changed

  • Attention Rising: 41 mentions on 30 Oct 2026, against 31 on 9 Oct 2026 (+32%).
  • State No change in coverage state or wire tier recorded since 18 Oct 2026.
  • Claims No claim first reported since 29 Oct 2026.

How well we know this

448 documents · 131 publishers · 6% contain a typed assertion · last evidence 30 Oct 2026

  • Gap: assertion coverage 0.056: about 94% of mentions carry no typed assertion

In this snapshot’s daily coverage:

Reported alongside Eli Lilly

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

GLP-1AIFDAUnited StatesChina
  • GLP-1 · 134 shared documents
  • AI · 127 shared documents
  • FDA · 124 shared documents
  • Weight Loss · 85 shared documents · no page of its own yet
  • Novo Nordisk · 79 shared documents · no page of its own yet
  • United States · 69 shared documents
  • China · 66 shared documents
  • Buy · 57 shared documents · no page of its own yet
  • Zepbound · 56 shared documents · no page of its own yet
  • Clinical Trials · 54 shared documents · no page of its own yet

Story momentum

Rising

The word compares 41 mentions on 30 Oct 2026 with 31 on 9 Oct 2026 (+32%); a change of less than 8% either way reads Steady.

Daily mentions +486% from 15 Sept 2026 to 30 Oct 2026, between 5 and 43 a day

How often tracked coverage mentions Eli Lilly, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about Eli Lilly yet. Ask about Eli Lilly

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/85a46c3fe31041288a0a56c9 returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name eli lilly.

{
  "name": "eli lilly",
  "label": "Eli Lilly",
  "asOf": "2026-10-30",
  "mentions": 79,
  "outlets": 26,
  "domains": 19,
  "node": {
    "id": "sb:e/85a46c3fe31041288a0a56c9",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/85a46c3fe31041288a0a56c9",
    "knowledgeCutoff": "2026-10-30T17:26:31.382671+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "rising",
  "history": {
    "since": "2026-10-18T15:52:54.951886+00:00",
    "changes": 0
  },
  "whereFrom": {
    "level": "counts",
    "label": "79 mentions across 19 domains",
    "children": [
      {
        "level": "reports",
        "label": "6 reports drawn on this page, each with its link",
        "children": {
          "count": 6,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "19 coverage domains",
        "children": {
          "count": 18,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 73 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving Eli Lilly

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

  • Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

    Reported claim · first reported 28 Oct 2026 · 1 claim · best-carried claim: 4 separate publishers

    corroborated

  • New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer

    Reported claim · first reported 24 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

Walk the record from Eli Lilly

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

Eli Lilly

Entity.

Evidence
448 documents · 131 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 6 May 2026, last seen 30 Oct 2026
Measured
6% of mentions say something specific about it; the rest only name it
As of
30 Oct 2026
12 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (2)

  • Corroborated: Reported by three or more sources that did not copy each other.
  • Single source: Reported by one source so far.

Situations it is named in (0)

none on file at this cutoff

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names Eli Lilly, newest first. Open any row to follow it to the original article.

Evidence tiers: primary source = an official public record · attributed = a named outlet, receipt linked · lead = observed, not yet receipted.

What it connects to

Related records.

Pull a thread

Recorded history

No change in coverage state or wire tier recorded since 18 Oct 2026.

Ask about Eli LillyWatch Eli Lilly

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 30 Oct 2026.